Spruce Biosciences, Inc. Proceeds from Warrant Exercises
Spruce Biosciences, Inc. (SPRB) reported Proceeds from Warrant Exercises of $40.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-03-09
- Spruce Biosciences, Inc. proceeds from warrant exercises for the quarter ending 2024-12-31 was $0.00.
- Spruce Biosciences, Inc. proceeds from warrant exercises for the quarter ending 2024-09-30 was $0.00.
- Spruce Biosciences, Inc. proceeds from warrant exercises for the quarter ending 2023-12-31 was $0.00.
- Spruce Biosciences, Inc. proceeds from warrant exercises for the quarter ending 2023-09-30 was $0.00.
- Spruce Biosciences, Inc. proceeds from warrant exercises for fiscal 2025 was $40.00K.
- Spruce Biosciences, Inc. proceeds from warrant exercises for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Spruce Biosciences, Inc. proceeds from warrant exercises for fiscal 2023 was $8.00K.
- Spruce Biosciences, Inc. proceeds from warrant exercises for fiscal 2022 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2025-12-31 | $40.00K 10-K · filed 2026-03-09 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $8.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $8.00K 10-Q · filed 2024-08-12 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $0.00 10-K · filed 2024-03-18 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |